Back
Antero Resources 10K Form
Sell
27
AR
Antero Resources
Last Price:
$30.94
Seasonality Move:
6.35%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-10-25 | 10Q | AR/Antero Resources Quarterly |
2023-07-26 | 10Q | AR/Antero Resources Quarterly |
2023-04-26 | 10Q | AR/Antero Resources Quarterly |
2022-10-26 | 10Q | AR/Antero Resources Quarterly |
2022-07-27 | 10Q | AR/Antero Resources Quarterly |
2022-04-27 | 10Q | AR/Antero Resources Quarterly |
Receive AR News And Ratings
See the #1 stock for the next 7 days that we like better than AR
AR Financial Statistics
Sales & Book Value
Annual Sales: | $4.3B |
---|---|
Cash Flow: | $139.6M |
Price / Cash Flow: | 12.23 |
Annual Sales: | $22.44 |
Price / Book: | 1.38 |
Profitability
EPS (TTM): | 0.14000 |
---|---|
Net Income (TTM): | $45M |
Gross Margin: | $669.4M |
Return on Equity: | 0.63% |
Return on Assets: | 0.33% |
Antero Resources Earnings Forecast
Key Antero Resources Financial Ratios
-
The Gross Profit Margin over the past 14 years for AR is 15.64%.
-
The Selling, General & Administrative Expenses for AR have been equal to 11.91% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 48.52% of Operating Income.
-
The Net Earning history of AR is 5.68% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 8 years.
Antero Resources Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Oil, Gas & Consumable Fuels |
Sector: | Energy |
Current Symbol: | AR |
CUSIP: | 03674X |
Website: | anteroresources.com |
Debt
Debt-to-Equity Ratio: | 0.23 |
---|---|
Current Ratio: | 0.28 |
Quick Ratio: | 0.26 |
Price-to-Earnings
Trailing P/E Ratio: | 39.65 |
---|---|
Forward P/E Ratio: | 15.23 |
AR Technical Analysis vs Fundamental Analysis
Sell
27
Antero Resources (AR)
is a Sell
Is Antero Resources a Buy or a Sell?
-
Antero Resources stock is rated a SellThe current Antero Resources [AR] share price is $30.93. The Score for AR is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.